Alpha Tau Medical Ltd (DRTS) Price Prediction & ForecastDRTSAlpha Tau Medical Ltd

Alphio's DRTS stock price prediction model matches the current Alpha Tau Medical Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.64 (-0.03%). The 1-week path is $14.66 (+0.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Alpha Tau Medical Ltd (DRTS) is a good buy right now, trading at $14.64 with a strong year-to-date change of +203.11%. The RSI is at 56.24, indicating a healthy momentum. Analyst price targets suggest a potential upside of 9% to 16% based on recent upgrades, with H.C. Wainwright targeting $16 and Barclays at $17. The main risk is the negative EPS trend, with a reported EPS of -0.50, reflecting ongoing losses, but the dual listing and FDA approvals could drive future growth.

Alpha Tau Medical Ltd (DRTS) last closed at $14.64, losing -1.15%. These facts feed the 1-day and 1-week DRTS price prediction above.